Dr. Weinblatt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Brigham & Womens Hospital Arthritis Center
Boston, MA 02115Phone+1 617-732-5331Fax+1 617-264-5208
Education & Training
- Brigham and Women's HospitalFellowship, Rheumatology, 1978 - 1980
- University of MarylandResidency, Internal Medicine, 1975 - 1978
- University of Maryland School of MedicineClass of 1975
Certifications & Licensure
- ME State Medical License Current
- FL State Medical License 2022 - 2025
- MA State Medical License 1978 - 2025
- NC State Medical License 1980 - 1999
- MD State Medical License 1977 - 1981
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Boston Magazine Castle Connolly, 2008-2013
- Boston Herald Castle Connolly, 2005
- Join now to see all
Clinical Trials
- Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1) Start of enrollment: 2006 Aug 01
Publications & Presentations
PubMed
- 1378 citationsAdalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: ...Michael E. Weinblatt, Edward C. Keystone, Daniel E. Furst, Larry W. Moreland, Michael H. Weisman
Arthritis and Rheumatism. 2003-01-01 - 322 citationsDe Novo Copy Number Variants Identify New Genes and Loci in Isolated, Sporadic Tetralogy of FallotSteven C. Greenway, Alexandre C. Pereira, Jennifer C Lin, Steven R. DePalma, Samuel J Israel
Nature Genetics. 2009-07-13 - 218 citationsEfficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis...Michael H. Weisman, Larry W. Moreland, Daniel E. Furst, Michael E. Weinblatt, Edward C. Keystone
Clinical Therapeutics. 2003-06-01
Journal Articles
- ABT‐122, a Bispecific DVD‐Immunoglobulin Targeting TNF– and IL‐17A, in RA with Inadequate Response to Methotrexate: A Randomized, Double‐Blind StudyMichael E Weinblatt, Mark C Genovese, Jacob A Aelion, Arthritis & Rheumatology
Press Mentions
- Data Now Out for Pegloticase-MTX Combo Gout TreatmentSeptember 16th, 2022
- SciRhom Establishes a World-Class Clinical Advisory BoardDecember 15th, 2021
- Study Quantifies Herpes Zoster Risk with JAK Inhibitors, Other DMARDsJune 8th, 2021
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: